Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the production of advanced fuels and chemicals through the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into advanced Biorefineries. Aemetis continues to achieve important milestones that are creating significant value for shareholders. Aemetis is seeking to commercialize the conversion of first generation biodiesel and ethanol plants into integrated production facilities that produce an expanded portfolio of higher value products, such as renewable jet fuel, renewable diesel, renewable chemicals, as well as valuable products from liquefied CO2.
Aemetis has received $35 million in EB-5 funding and has $150 million in revenues. The company has over 130 employees worldwide, and is publicly traded on the NASDAQ stock market under the symbol AMTX.
Congress created the EB-5 program in 1990 to benefit the US economy and create new jobs by attracting investments from qualified foreign investors who were granted a path to US citizenship through an investment of $500,000 into a qualified project. We view the EB-5 program as a powerful tool with which we can invest in new technologies, expand the production of high value products, and create jobs. We are very pleased about the positive momentum our EB-5 project has gained in the past year, and look forward to expansion of our participation in the future.